NASDAQ · PRVA

Privia Health Group, Inc.

$24.67 -$0.83 (-3.25%) 1D After hours
Charting by TradingView

Key Metrics

$3.21B
Market cap
147.65×
P/E · TTM
—
Revenue · TTM
$21.76M
Net income
EPS · TTM $0.17
Dividend yield —
Free cash flow —
Beta · 1Y 0.70
EBITDA · TTM $56.39M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 26
    The stock moved +10.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.21B
Enterprise value—
Shares outstanding126.0M
52-wk range$18.77 – $28.82
Avg volume · 20D863.6K
Net cash —
Book value / share$5.89
IndustryServices-Health Services
ExchangeNASDAQ
About Privia Health Group, Inc.
IPO dateApr 29, 2021
Employees1226

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E147.65
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №$4.75

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC 3.1% · 8.2%

Financial Health

Current ratio1.61
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$364.72M

Cash Flow · TTM

Operating CF $138.00M
Capex —
Free cash flow —
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$4.75 vs $24.67
Trades 5.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings